Luminus Management Raised By $8.24 Million Its Vale S A (VALE) Holding; Paragon Capital Management Lowered Teva Pharm Inds LTD F Adr 1 Ad (TEVA) Position

August 23, 2017 - By Darrin Black

Luminus Management Llc increased Vale S A (VALE) stake by 130.13% reported in 2016Q4 SEC filing. Luminus Management Llc acquired 1.18M shares as Vale S A (VALE)’s stock declined 20.71%. The Luminus Management Llc holds 2.08M shares with $15.86M value, up from 904,159 last quarter. Vale S A now has $54.82 billion valuation. The stock rose 3.05% or $0.31 reaching $10.31 per share. About 20.24M shares traded. Vale SA (ADR) (NYSE:VALE) has risen 111.11% since August 23, 2016 and is uptrending. It has outperformed by 94.41% the S&P500.

Paragon Capital Management Llc decreased Teva Pharm Inds Ltd F Adr 1 Ad (TEVA) stake by 11.77% reported in 2016Q4 SEC filing. Paragon Capital Management Llc sold 21,197 shares as Teva Pharm Inds Ltd F Adr 1 Ad (TEVA)’s stock declined 15.11%. The Paragon Capital Management Llc holds 158,904 shares with $5.76M value, down from 180,101 last quarter. Teva Pharm Inds Ltd F Adr 1 Ad now has $16.68 billion valuation. The stock declined 2.91% or $0.5 reaching $16.51 per share. About 13.11 million shares traded. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since August 23, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.

Among 27 analysts covering Teva Pharma (NYSE:TEVA), 6 have Buy rating, 2 Sell and 19 Hold. Therefore 22% are positive. Teva Pharma had 83 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) earned “Perform” rating by Oppenheimer on Thursday, August 3. The rating was upgraded by Bank of America to “Buy” on Tuesday, January 31. The firm has “Buy” rating by Mizuho given on Thursday, August 25. The firm earned “Hold” rating on Friday, July 14 by Piper Jaffray. The firm earned “Neutral” rating on Wednesday, May 4 by Credit Suisse. The firm has “Market Perform” rating given on Friday, August 4 by Bernstein. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has “Neutral” rating given on Friday, June 16 by Cantor Fitzgerald. Mizuho maintained it with “Buy” rating and $75 target in Tuesday, May 10 report. RBC Capital Markets maintained it with “Buy” rating and $3800 target in Friday, June 16 report. As per Tuesday, July 25, the company rating was maintained by Jefferies.

Luminus Management Llc decreased Honeywell Intl Inc (NYSE:HON) stake by 164,175 shares to 451,535 valued at $52.31 million in 2016Q4. It also reduced Flowserve Corp (NYSE:FLS) stake by 67,000 shares and now owns 43,000 shares. Oge Energy Corp (NYSE:OGE) was reduced too.

Among 24 analysts covering Vale S.A. (NYSE:VALE), 10 have Buy rating, 1 Sell and 13 Hold. Therefore 42% are positive. Vale S.A. had 58 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with “Hold” on Friday, July 28. The stock of Vale SA (ADR) (NYSE:VALE) has “Hold” rating given on Thursday, July 13 by Cowen & Co. BMO Capital Markets maintained the shares of VALE in report on Monday, July 31 with “Hold” rating. The firm earned “Neutral” rating on Wednesday, December 7 by Credit Suisse. The firm has “Hold” rating by Societe Generale given on Monday, May 9. The company was upgraded on Wednesday, October 28 by HSBC. Stifel Nicolaus downgraded the shares of VALE in report on Thursday, March 10 to “Hold” rating. The firm earned “Hold” rating on Friday, July 28 by RBC Capital Markets. The stock has “Hold” rating by Credit Suisse on Thursday, July 27. The rating was maintained by Cowen & Co on Friday, November 20 with “Market Perform”.